Disciplina Capital Management’s Novo Nordisk NVO Stock Holding History

Disciplina Capital Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$15.3K	Hold	416	–	–	﹤0.01%	62
2025 Q4	$21.2K	Hold	416	–	–	﹤0.01%	62
2025 Q3	$23.1K	Hold	416	–	–	﹤0.01%	56
2025 Q2	$28.7K	Sell	416 -64	-13%	-$4.35K	﹤0.01%	56
2025 Q1	$33.3K	Buy	480 +297	+162%	+$24.5K	﹤0.01%	55
2024 Q4	$15.7K	Hold	183	–	–	﹤0.01%	58
2024 Q3	$21.8K	Buy	+183	New	+$24.4K	﹤0.01%	56

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $147M AUM 25.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

Disciplina Capital Management's NVO Position: Q1 2026 in Review

Disciplina Capital Management held its Novo Nordisk (NVO) position steady in Q1 2026 at 416 shares worth $15.3K. The position accounts for ﹤0.01% of the portfolio, ranked #62.

Disciplina Capital Management first reported a position in NVO in Q3 2024 and has held it in 7 quarters since. The position peaked at $33.3K in Q1 2025. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

Disciplina Capital Management held 416 shares of Novo Nordisk worth $15.3K as of Q1 2026.
Disciplina Capital Management left its Novo Nordisk share count unchanged in Q1 2026.
Novo Nordisk made up ﹤0.01% of Disciplina Capital Management's portfolio in Q1 2026, its #62 holding.
Disciplina Capital Management first reported a position in Novo Nordisk in Q3 2024 and has held it in 7 quarters since.
Disciplina Capital Management's Novo Nordisk position peaked at $33.3K in Q1 2025.
1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on Disciplina Capital Management's 13F filing for Q1 2026, filed 7 May 2026.